188 related articles for article (PubMed ID: 16314616)
1. Hormone replacement therapy is associated with decreased survival in women with lung cancer.
Ganti AK; Sahmoun AE; Panwalkar AW; Tendulkar KK; Potti A
J Clin Oncol; 2006 Jan; 24(1):59-63. PubMed ID: 16314616
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population.
Huang B; Carloss H; Wyatt SW; Riley E
Cancer; 2009 Sep; 115(18):4167-75. PubMed ID: 19526591
[TBL] [Abstract][Full Text] [Related]
3. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study.
Ramnath N; Menezes RJ; Loewen G; Dua P; Eid F; Alkhaddo J; Paganelli G; Natarajan N; Reid ME
Oncology; 2007; 73(5-6):305-10. PubMed ID: 18493157
[TBL] [Abstract][Full Text] [Related]
4. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F
J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876
[TBL] [Abstract][Full Text] [Related]
5. Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy.
Schuetz F; Diel IJ; Pueschel M; von Holst T; Solomayer EF; Lange S; Sinn P; Bastert G; Sohn C
Am J Obstet Gynecol; 2007 Apr; 196(4):342.e1-9. PubMed ID: 17403414
[TBL] [Abstract][Full Text] [Related]
6. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
[TBL] [Abstract][Full Text] [Related]
7. The long-term impact of 2-3 years of hormone replacement therapy on cardiovascular mortality and atherosclerosis in healthy women.
Alexandersen P; Tankó LB; Bagger YZ; Qin G; Christiansen C
Climacteric; 2006 Apr; 9(2):108-18. PubMed ID: 16698657
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy before breast cancer diagnosis significantly reduces the overall death rate compared with never-use among 984 breast cancer patients.
Jernström H; Frenander J; Fernö M; Olsson H
Br J Cancer; 1999 Jul; 80(9):1453-8. PubMed ID: 10424750
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
Windler E; Zyriax BC; Eidenmüller B; Boeing H
Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer in postmenopausal women with and without hormone replacement therapy: preliminary results of the MISSION study.
Espié M; Mares P; de Reilhac P; Chevallier T; Daurès JP
Gynecol Endocrinol; 2006 Aug; 22(8):423-31. PubMed ID: 17012103
[TBL] [Abstract][Full Text] [Related]
11. Type and duration of exogenous hormone use affects breast cancer histology.
Kumar AS; Cureton E; Shim V; Sakata T; Moore DH; Benz CC; Esserman LJ; Hwang ES
Ann Surg Oncol; 2007 Feb; 14(2):695-703. PubMed ID: 17103262
[TBL] [Abstract][Full Text] [Related]
12. Smoking cessation before diagnosis and survival in early stage non-small cell lung cancer patients.
Zhou W; Heist RS; Liu G; Park S; Neuberg DS; Asomaning K; Wain JC; Lynch TJ; Christiani DC
Lung Cancer; 2006 Sep; 53(3):375-80. PubMed ID: 16814423
[TBL] [Abstract][Full Text] [Related]
13. Persistence with oral and transdermal hormone replacement therapy and hospitalisation for cardiovascular outcomes.
Corrao G; Zambon A; Nicotra F; Fornari C; La Vecchia C; Mezzanzanica M; Nappi RE; Merlino L; Cesana G
Maturitas; 2007 Jul; 57(3):315-24. PubMed ID: 17485182
[TBL] [Abstract][Full Text] [Related]
14. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort.
Rodriguez C; Spencer Feigelson H; Deka A; Patel AV; Jacobs EJ; Thun MJ; Calle EE
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):655-60. PubMed ID: 18349283
[TBL] [Abstract][Full Text] [Related]
15. Association of positive family history with survival of patients with lung cancer.
Ganti AK; Loberiza FR; Kessinger A
Lung Cancer; 2009 Jan; 63(1):136-9. PubMed ID: 18573566
[TBL] [Abstract][Full Text] [Related]
16. Impact of hormone replacement therapy on the histologic subtype of breast cancer.
Zanetti-Dällenbach RA; Krause EM; Lapaire O; Gueth U; Holzgreve W; Wight E
Arch Gynecol Obstet; 2008 Nov; 278(5):443-9. PubMed ID: 18335229
[TBL] [Abstract][Full Text] [Related]
17. Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer.
Kaufman EL; Jacobson JS; Hershman DL; Desai M; Neugut AI
J Clin Oncol; 2008 Jan; 26(3):392-8. PubMed ID: 18202415
[TBL] [Abstract][Full Text] [Related]
18. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
19. Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis.
Fletcher AS; Erbas B; Kavanagh AM; Hart S; Rodger A; Gertig DM
Breast; 2005 Jun; 14(3):192-200. PubMed ID: 15927828
[TBL] [Abstract][Full Text] [Related]
20. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
